Skip to main content
. 2016 Aug 31;7(51):84142–84154. doi: 10.18632/oncotarget.11776

Figure 6. Pharmacological correlates of PI3K-Akt-mTOR pathway activity.

Figure 6

(A) Correlation of DRS with AKT Inhibitor VIII IC50. Each point represents a single cell line. (B) Correlation between DRS and the IC50 of 53 drugs. Blue colored drug names are chemotherapeutics and red colored drug names are targeted inhibitors.